A detailed history of Jb Capital LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Jb Capital LLC holds 31,642 shares of EXAS stock, worth $2.12 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
31,642
Previous 21,914 44.39%
Holding current value
$2.12 Million
Previous $1.16 Million 48.71%
% of portfolio
0.08%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$40.91 - $56.0 $397,972 - $544,768
9,728 Added 44.39%
31,642 $1.73 Million
Q2 2025

Jul 24, 2025

BUY
$40.31 - $58.08 $883,353 - $1.27 Million
21,914 New
21,914 $1.16 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Jb Capital LLC Portfolio

Follow Jb Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jb Capital LLC with notifications on news.